STX-0712

· Solu Therapeutics, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for STX-0712, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) [Phase 1]